Zhi-Ping Wang

Zhi-Ping Wang

Auto-generated profile, based on publicly available information

Zhi-Ping Wang

Department of Anesthesiology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2011 in Cell Biochemistry and Biophysics
Verified
Journal Article
Closed access
PDF file
ZWZhi-Ping Wang
Zhi-Ping Wang
HCHong-Sheng Chen
Hong-Sheng Chen
FWFeng-Xiang Wang
Feng-Xiang Wang

1 October 2015 in Brain Research
Verified
Journal Article
Closed access
YWYuan-Lin Wang
Yuan-Lin Wang
XCXin Chen
Xin Chen
ZWZhi-Ping Wang
Zhi-Ping Wang

2 July 2022 in International Journal of Obstetric Anesthesia
Verified
Journal Article
Closed access
RZR.H. Zuo
R.H. Zuo
JDJ.J. Dang
J.J. Dang
JZJ.W. Zhuang
J.W. Zhuang
QCQ.M. Chen
Q.M. Chen
JZJ.Y. Zhang
J.Y. Zhang
ZWZ.P. Wang
Z.P. Wang

18 May 2024 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
SZSiqi Zhou
Siqi Zhou
ZWZhangding Wang
Zhangding Wang
DZDian Zhao
Dian Zhao
YFYao Fu
Yao Fu
SZShu Zhang
Shu Zhang
XZXiaoping Zou
Xiaoping Zou
Background: Human endogenous retrovirus subfamily H long terminal repeat associating protein 2, (HHLA2), a member of B7 family, exhibits heightened expression in various malignant tumors. However, the exact functions of HHLA2 in pancreatic cancer (PC) remain incompletely elucidated. Methods: We initially conducted an analysis of the B7 family members’ expression pattern in pancreatic tumor samples and adjacent normal tissues using The Cancer Genome Atlas (TCGA) database. Subsequently, immunohistochemistry, RT-qPCR and western blot methods were used to assess HHLA2 expression levels in PC tissues and cell lines. Furthermore, after silencing HHLA2 in PC cell lines, cell migration and proliferation of PC cells were detected by wound healing and CCK-8 assays, and cell invasion of PC cells was detected by transwell assays. We also investigated the regulation of epithelial-mesenchymal transition (EMT) markers and levels of EGFR, MEK, ERK1/2, mTOR and AKT via western blot analysis. Finally, the correlation between HHLA2 expression and immune infiltration was further explored. Results: Silencing of HHLA2 resulted in the inhibition of PC cell proliferation, migration and invasion, potentially through the suppression of the EGFR/MAPK/ERK and mTOR/AKT signaling pathway. Additionally, silencing HHLA2 led to the inhibition of M2-type polarization of tumor associated macrophages (TAMs). Conclusion: The knockdown of HHLA2 was observed to inhibit the migration and invasion of PC cells through the regulation of the EMT process and EGFR/MAPK/ERK and mTOR/AKT pathway. Furthermore, silencing HHLA2 was found to modulate M2 polarization of TAMs. These finding suggest that HHLA2 could be a promising therapeutic target for Pancreatic cancer.

22 November 2019 in BMC Anesthesiology
Verified
Journal Article
Open access
PDF file
ZGZhengfeng Gu
Zhengfeng Gu
LXLian Xin
Lian Xin
HWHaoxing Wang
Haoxing Wang
CHChunxiao Hu
Chunxiao Hu
ZWZhiping Wang
Zhiping Wang
JWJun Wang
Jun Wang
Background: Painless gastrointestinal endoscopy under intravenous propofol anesthesia is widely applied in the clinical scenario. Despite the good sedation and elimination of anxiety that propofol provides, low SpO2 may also result. Doxapram is a respiratory stimulant with a short half-life. The primary aim of this study was to investigate the effects of doxapram on alleviating low SpO2 induced by the combination of propofol and fentanyl during painless gastrointestinal endoscopy. Methods: In this prospective study, patients scheduled for painless gastrointestinal endoscopy were randomly assigned to group D or S with 55 patients per group. Initially, both groups received a combination of propofol and fentanyl. Patients in group D received 50 mg doxapram after propofol injection, while patients in group S received an equal volume of saline. Vital signs of the patients, propofol dose, examination duration, and incidences of low SpO2 were recorded. Results: There were no statistical differences in propofol consumption and examination duration between the two groups. Twenty-six patients in group S experienced low SpO2 versus 10 in group D (P = 0.001). Nineteen patients in group S underwent oxygenation with a face mask in contrast to 8 in group D (P = 0.015). Eighteen patients in group S were treated with jaw lifting compared to 5 in group D (P = 0.002). Four patients in group S underwent assisted respiration compared to 2 in group D (without statistical difference). The average oxygen saturation in group S was significantly lower than that in group D at 1, 2 and 3 min after propofol injection (P < 0.001, P = 0.001 and P = 0.020, respectively). There were no statistical differences in oxygen saturation at other time points. There were no statistical differences in MAP and HR (except for the time point of 1 min after the induction) between the two groups. Conclusions: Low dose of doxapram can effectively alleviate low SpO2 in painless gastrointestinal endoscopy with intravenous propofol, without affecting propofol consumption, examination duration, MAP, or HR. Trail registration: The study was approved by the Institutional Ethics Committee of Clinical and New Technology of Wuxi People’s Hospital on 20th July, 2018 (KYLLH2018029) and registered in the Chinese Clinical Trial Register on 16th August, 2018 (ChiCTR1800017832).

25 June 2006
Verified
Journal Article
Closed access
ZWZhi-Ping Wang
Zhi-Ping Wang
ZZZhao-Hang Zhang
Zhao-Hang Zhang
YZYin-Ming Zeng
Yin-Ming Zeng
SJShan Jiang
Shan Jiang
SWShu-Qu Wang
Shu-Qu Wang
SWSheng Wang
Sheng Wang